GlassScriptPhysician profile
Dionne S Dickerson
NPI 1578579652
$1,326.02
in general payments reported to CMS, 2019-2025
23 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $71.16 · 2021: $271 · 2022: $77.44 · 2023: $149 · 2024: $250 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $783.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $279.40 | 2019-2022 | |
| Astellas Pharma US INC | $190.87 | 2023-2025 | Veozah |
| Sage Therapeutics, LLC | $159.97 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $118.80 | 2019-2025 | Acessa Provu System, Fluent Fluid Management System, Coolseal Generator |
| Pfizer INC. | $90.80 | 2021-2023 | |
| Novo Nordisk INC | $56.44 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Mayne Pharma Commercial LLC | $55.75 | 2023-2024 | |
| Exeltis, USA INC. | $47.56 | 2019-2025 | Slynd |
| Organon LLC | $47.08 | 2025 | Nexplanon |
| Coopersurgical, INC. | $45.24 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Baxter Healthcare | $34.03 | 2025 | Tisseel, Perclot |
| Sumitomo Pharma America, INC. | $27.14 | 2025 | Myfembree |
| Myovant Sciences INC. | $25.21 | 2021 | |
| Ethicon US, LLC | $23.82 | 2024 | Vistaseal, Surgicel Nu-Knit, Enseal |
| Amgen INC. | $20.11 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $15.65 | 2020 | |
| Supernus Pharmaceuticals, INC. | $14.57 | 2025 | Qelbree |
| Exact Sciences Corporation | $14.53 | 2025 | The Cologuard Plus Collection Kit |
| Avion Pharmaceuticals | $13.25 | 2020 | |
| Shield Therapeutics INC | $12.84 | 2022 | |
| Mylan Pharmaceuticals INC. | $12.05 | 2019 | |
| Therapeuticsmd, INC. | $11.20 | 2019 | |
| Meditrina | $9.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dionne Dickerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.